Dr. Ali Jaan, Dr. Muhammad Tayyeb, Dr. Farhan Khalid, Dr. Aftab Sharif, Dr. Dania Rahim Qureshi, Dr. Sarfaraz Ahmad, Dr. Zahoor Ahmed and Dr. Anum Awais*


The spread of Severe acute respiratory syndrome 2 (SARS-Cov-2), the causative agent of coronavirus disease (COVID-19) has become a public health emergency. The whole world is concerned about the pandemic of COVID-19 caused by widespread SARS-CoV-2 across the globe. This new disease and its causative virus have drawn its major global attention. The number of patients and death rates are continuously increasing. The research community and scientists have been conducting a major campaign to understand this new emergent disease and its epidemiology to uncover possible treatment regimens, discover effective therapeutic agents, and develop vaccines. Since SARS-CoV-2 is a newly discovered pathogen, no specific drugs have been identified or are currently available. Although, a few candidates have shown efficacy in vitro studies, as well as in pre-clinical studies, and some drugs have also shown efficacy in clinical practice, but not a single drug has proven effective in large clinical randomized clinical trials. This review summarizes the ongoing advances and clinical trials designing the therapeutics against COVID-19. The whole is waiting for the results of these clinical trials as a potential treatment against COVID-19.

Keywords: COVID-19, coronavirus, pharmacotherapy, treatment.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    DECEMBER 2023 Issue has been successfully launched on 1 DECEMBER 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction